Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Doing our part to improve drug safety

Posted on October 2nd, 2018 by in Pharma R&D

Pharmacovigilance and drug safety teams are never short of work. There’s a vast amount of peer-reviewed literature to sift through for adverse event information. Over 800,000 pharmacology and biomedicine articles (more…)

Outsourcing PV: Selecting your Partner

Posted on January 23rd, 2017 by in Pharmacovigilance

Once you know what functions and expertise you want to keep in house and what are the PV activities you want to outsource, the next challenge will be to identify potential partners and pick-up the one which will fit your PV needs for the years to come. (more…)

Easing the Pain in Monitoring Literature for Adverse Drug Events

Posted on September 20th, 2016 by in Pharmacovigilance

Over the past year, we have heard about the various challenges associated with the cumbersome task of monitoring scientific literature for adverse drug events (AE) from thought leaders on this blog. Pharmacovigilance professionals have written about the literature monitoring and review process, the recent EMA Medical Literature Monitoring initiative, and the importance of literature search strategies. (more…)